CJC-1295 NO DAC 5mg With 5mg Ipamorelin

CJC-1295 (No DAC) and Ipamorelin are synthetic peptides frequently studied in laboratory environments for their interaction with growth hormone–related signaling pathways. CJC-1295 (No DAC) is a modified analog of growth hormone releasing hormone (GHRH), while Ipamorelin is a selective growth hormone secretagogue studied for its interaction with the ghrelin receptor.

When combined in a research setting, these peptides are commonly investigated together in experimental models examining peptide receptor interaction, endocrine signaling pathways, and growth hormone regulatory mechanisms. Researchers often explore this peptide pairing to study how multiple signaling pathways may interact within controlled laboratory conditions.

Research Applications
• Growth hormone signaling pathway research
• Peptide receptor interaction studies
• Endocrine signaling investigations
• Peptide synergy and signaling pathway analysis

Product Specifications
• Compound: CJC-1295 (No DAC) / Ipamorelin Blend
• Quantity: 5mg CJC-1295 (No DAC) + 5mg Ipamorelin
• Form: Lyophilized peptide powder
• Purity: ≥98% (HPLC verified)
• Packaging: Sterile sealed research vial

Storage
Store refrigerated at 2–8°C. For long-term storage, freezing at -20°C is recommended to preserve peptide stability.

Notice
This product is intended strictly for laboratory research purposes only and is not intended for human consumption, medical use, or veterinary use.